Estás en: Inicio > Página Raíz Instituto Mixto Universidad Carlos III de Madrid - Banco de Santander en Big Data Financiero (IC3BS) > People > lopez_bonilla

Luis López Bonilla

Contact Information

Professor Luis L. Bonilla holds a PhD in Physics (Universidad Nacional de Educacion a Distancia, 1981), BS & MS in Physics (Universidad Autónoma de Madrid, 1978). He was a Postdoctoral Fulbright fellow in Mathematics at Stanford University (1983-85). Professor Bonilla has been a full professor of Applied Mathematics at Universidad Carlos III de Madrid since 1992, previously associate professor of Condensed Matter Physics at University of Barcelona (1990-91) and associate professor of Theoretical Physics at University of Seville (1987-90). Recent sabbatical stays as visiting professor include Stanford University (2010) and Harvard University (2012). He is a member of the editorial boards of various international journals, scientific and organizing committees of international conferences, and has served in governing councils and boards of international organizations such as the International Council of Industrial and Applied Mathematics, the European Consortium for Mathematics in Industry (President, Vicepresident and Chair of the Educational Committee), and in the OECD Panel for Industrial Mathematics.

Professor Bonilla is an expert modeller in different scientific fields (condensed matter physics, materials science, nanoelectronics, biomedicine, …) and an expert on asymptotic analysis of differential equations. He has been the director of the Gregorio Millan Institute for Modeling and Simulation in Fluid Dynamics, Nanoscience and Industrial Mathematics of Universidad Carlos III since it started in 2007. In the field of Big Data, Professor Bonilla is interested in applications to Biomedicine, studying formation and growth of blood vessels (angiogenesis) that play an important role in diseases of inflammatory basis such as retinopathies or musculoskeletal conditions. Collaboration with hospitals, genomic data companies and biology laboratories is being established to contribute understanding of these complex diseases and search for optimal therapies.